Glenn Crater Selected Research

Glenn Crater Research Topics

21	Chronic Obstructive Pulmonary Disease (COPD) 10/2019 - 08/2008
3	Dyspnea (Shortness of Breath) 05/2014 - 10/2009
2	Inflammation (Inflammations) 02/2016 - 01/2014
1	Albuminuria 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Hyperplasia 01/2023
1	Polyuria 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Atrial Fibrillation 01/2019
1	Asthma (Bronchial Asthma) 02/2016
1	Airway Obstruction (Choking) 11/2009
1	Cough 11/2009

9	GSK573719IBA 12/2014 - 07/2012
8	Bronchodilator Agents (Bronchodilators)IBA 10/2019 - 11/2009
8	Muscarinic AntagonistsIBA 10/2019 - 10/2012
6	Tiotropium Bromide (Spiriva)FDA Link 10/2019 - 02/2012
5	revefenacinIBA 10/2019 - 01/2019
5	vilanterolIBA 12/2014 - 12/2012
4	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 02/2012 - 08/2008
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2019 - 01/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2016 - 10/2009
3	Albuterol (Salbutamol)FDA LinkGeneric 05/2014 - 08/2008
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2013 - 07/2012
1	Urea (Carbamide)FDA LinkGeneric 01/2023
1	AlbuminsIBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	Streptozocin (Streptozotocin)FDA Link 01/2023
1	Therapeutic UsesIBA 10/2019
1	SolutionsIBA 01/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	CytokinesIBA 02/2016
1	GoldIBA 01/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2013
1	Verapamil (Calan)FDA LinkGeneric 01/2013
1	Cytochrome P-450 CYP3A InhibitorsIBA 01/2013
1	Cytochrome P-450 CYP3AIBA 01/2013
1	insulin receptor-related receptor (IRR)IBA 01/2012
1	SmokeIBA 11/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2009
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 08/2008

9	Therapeutics 10/2019 - 03/2011
1	Drug Therapy (Chemotherapy) 01/2012